Free Trial

TransMedics Group (TMDX) Competitors

$138.42
-0.20 (-0.14%)
(As of 05/21/2024 ET)

TMDX vs. ITGR, LIVN, MASI, CNMD, INMD, SLNO, INSP, CRSP, NUVL, and ALPN

Should you be buying TransMedics Group stock or one of its competitors? The main competitors of TransMedics Group include Integer (ITGR), LivaNova (LIVN), Masimo (MASI), CONMED (CNMD), InMode (INMD), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), CRISPR Therapeutics (CRSP), Nuvalent (NUVL), and Alpine Immune Sciences (ALPN). These companies are all part of the "medical" sector.

TransMedics Group vs.

TransMedics Group (NASDAQ:TMDX) and Integer (NYSE:ITGR) are both mid-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, dividends, institutional ownership, risk, earnings, analyst recommendations and media sentiment.

99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 99.3% of Integer shares are held by institutional investors. 7.0% of TransMedics Group shares are held by insiders. Comparatively, 2.0% of Integer shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Integer has higher revenue and earnings than TransMedics Group. TransMedics Group is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
TransMedics Group$241.62M18.87-$25.03M-$0.34-407.12
Integer$1.60B2.54$90.65M$2.8941.94

In the previous week, Integer had 7 more articles in the media than TransMedics Group. MarketBeat recorded 13 mentions for Integer and 6 mentions for TransMedics Group. Integer's average media sentiment score of 0.69 beat TransMedics Group's score of 0.55 indicating that Integer is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
TransMedics Group
3 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
6 Very Positive mention(s)
2 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Integer received 290 more outperform votes than TransMedics Group when rated by MarketBeat users. Likewise, 63.51% of users gave Integer an outperform vote while only 54.78% of users gave TransMedics Group an outperform vote.

CompanyUnderperformOutperform
TransMedics GroupOutperform Votes
86
54.78%
Underperform Votes
71
45.22%
IntegerOutperform Votes
376
63.51%
Underperform Votes
216
36.49%

TransMedics Group has a beta of 1.87, indicating that its share price is 87% more volatile than the S&P 500. Comparatively, Integer has a beta of 1.12, indicating that its share price is 12% more volatile than the S&P 500.

TransMedics Group currently has a consensus price target of $119.00, suggesting a potential downside of 14.03%. Integer has a consensus price target of $128.67, suggesting a potential upside of 6.16%. Given Integer's higher possible upside, analysts clearly believe Integer is more favorable than TransMedics Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
TransMedics Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88
Integer
0 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.83

Integer has a net margin of 6.01% compared to TransMedics Group's net margin of -3.43%. Integer's return on equity of 11.25% beat TransMedics Group's return on equity.

Company Net Margins Return on Equity Return on Assets
TransMedics Group-3.43% 7.95% 1.61%
Integer 6.01%11.25%5.69%

Summary

Integer beats TransMedics Group on 12 of the 18 factors compared between the two stocks.

Get TransMedics Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for TMDX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TMDX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TMDX vs. The Competition

MetricTransMedics GroupElectromedical equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$4.56B$3.24B$5.02B$8.00B
Dividend YieldN/A1.66%42.66%3.91%
P/E Ratio-407.1210.22180.9618.67
Price / Sales18.8767.332,470.0384.54
Price / Cash969.3869.8032.8429.27
Price / Book32.963.965.014.46
Net Income-$25.03M$90.01M$104.15M$213.44M
7 Day Performance1.67%-1.68%0.31%0.46%
1 Month Performance60.00%-1.07%4.13%5.46%
1 Year Performance85.97%-2.77%4.84%8.75%

TransMedics Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
2.6503 of 5 stars
$121.20
+0.8%
$128.67
+6.2%
+50.7%$4.06B$1.60B41.9410,500
LIVN
LivaNova
1.4283 of 5 stars
$60.55
-1.2%
$66.20
+9.3%
+32.6%$3.28B$1.15B-100.912,900Positive News
MASI
Masimo
4.6837 of 5 stars
$124.52
-1.7%
$138.71
+11.4%
-23.8%$6.61B$2.05B84.715,200
CNMD
CONMED
4.9868 of 5 stars
$74.86
-0.6%
$107.86
+44.1%
-37.1%$2.31B$1.24B28.684,000Positive News
INMD
InMode
2.8373 of 5 stars
$18.75
-1.3%
$32.80
+74.9%
-43.8%$1.57B$492.05M8.89581
SLNO
Soleno Therapeutics
3.911 of 5 stars
$44.27
-5.8%
$60.33
+36.3%
+814.7%$1.48BN/A-16.5233
INSP
Inspire Medical Systems
4.9092 of 5 stars
$152.42
-1.8%
$256.53
+68.3%
-50.5%$4.53B$624.80M-277.131,011Positive News
CRSP
CRISPR Therapeutics
2.9914 of 5 stars
$54.76
-1.3%
$73.93
+35.0%
-11.9%$4.65B$371.21M-20.13473
NUVL
Nuvalent
2.8489 of 5 stars
$69.73
-1.7%
$90.78
+30.2%
+78.7%$4.47BN/A-28.9392
ALPN
Alpine Immune Sciences
1.8975 of 5 stars
$64.97
flat
$52.33
-19.5%
N/A$4.46B$58.88M-101.52142Positive News

Related Companies and Tools

This page (NASDAQ:TMDX) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners